Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Cardiff Oncology, Inc. (CRDF) had Pre-Tax Profit Margin of -8876.92% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.10M |
|
$-9.24M |
|
-- |
|
$0.10M |
|
$9.72M |
|
$-9.62M |
|
$0.38M |
|
$-9.23M |
|
$-9.23M |
|
$-9.23M |
|
$-9.23M |
|
$-9.23M |
|
$-9.23M |
|
$-9.62M |
|
$-9.59M |
|
68.40M |
|
68.40M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$35.59M |
|
$0.45M |
|
$1.74M |
|
$37.33M |
|
$10.80M |
|
-- |
|
-- |
|
$10.80M |
|
$26.53M |
|
$26.53M |
|
$26.53M |
|
68.50M |
|
| Cash Flow Statement Financials | |
$-24.05M |
|
$15.53M |
|
$0.25M |
|
$17.47M |
|
$9.20M |
|
$-8.27M |
|
$2.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-9245.19% |
|
-9245.19% |
|
-- |
|
|
Pre-Tax Profit Margin |
-8876.92% |
-8882.69% |
|
$-24.10M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.55 |
|
163.56 |
|
-34.80% |
|
-34.80% |
|
-24.73% |
|
-34.80% |
|
$0.39 |
|
$-0.35 |
|
$-0.35 |
|